secwatch.observer — SEC 8-K summary
======================================

Issuer:     CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CIK:        0001187953
Form:       8-K
Filed at:   2026-09-25T21:00:47+00:00
Accession:  0001477932-26-005805
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

CELZ buys 4M BioDefense shares for $200K cash plus 1M CELZ shares, lifting stake to 80%
--------------------------------------------------------------------------------

- Creative Medical Technology Holdings acquired 4,000,000 BioDefense, Inc. shares from Creative Acquisition Corp. for $200,000 cash plus 1,000,000 CELZ common shares; closing Sept. 24, 2026.
- After the deal CELZ holds 16,000,000 BioDefense shares (80% of outstanding), with seller CAC retaining 4,000,000 shares (20%).
- CAC is controlled by CELZ President/CEO Timothy Warbington, who is Chairman/CEO of CAC and indirectly owns all of its stock, making this a related-party transaction.
- The 1,000,000 CELZ shares were issued in a private placement under Section 4(a)(2) of the Securities Act and are unregistered, with transfer restrictions noted in the agreement.
- Agreement executed by Warbington for CAC and CFO Donald Dickerson for CELZ; governed by Nevada law, with a Stock Power transferring the 4M BioDefense shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1187953/000147793226005805/0001477932-26-005805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1187953/000147793226005805/celz_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-005805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer